In Stage 2 tests, Novo Nordisk’s medication prospect Cagrisema has actually currently shown weight management of even more 15% after 32 weeks.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/novo-nordisk-clinches-vital-obesity-data-as-bank-analysts-foresee-success/